Romosozumab does not appear to significantly increase the risk for cardiovascular disease (CVD) among patients with osteoporosis when compared with bisphosphonates, according to study results ...

The association of GDM with overall CVH and predicted cardiovascular disease (CVD) risk in mid-life remains to be defined among South Asian women in the US, a subgroup at excess risk for CVD. Methods: ...

AbbVie’s shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+10.2% vs. -12.5%). The Zacks analyst believes that the company’s medicines, Skyrizi and ...

Overweight or obesity prior to pregnancy may be an important marker of the trajectory of CVD risk in midlife, new data suggest. Among healthy pregnant adults with a mean age of 30, having a ...

MACE included incident stroke, myocardial infarction, and heart failure; CVD death; CVD mortality; and all-cause mortality. Any daily IPA amount of vigorous or moderate intensity was associated with ...

Notably, patients with narcolepsy started showing an excess subclinical CVD risk in early life, suggesting a potential role for early monitoring and treatment. The observational study was based on ...

The American Heart Association (AHA) released a scientific statement in Circulation about direct-to-consumer (DTC) genetic testing (GT) for cardiovascular disease (CVD). Multiple DTC-GT companies ...

CVD and obesity: When protective lipids decline, health risks increase. ScienceDaily . Retrieved April 29, 2025 from www.sciencedaily.com / releases / 2025 / 04 / 250408121322.htm ...

But the four Southeast Asian nations are subject to an antidumping and countervailing duty (AD/CVD) investigation, and if found in violation of AD/CVD laws, they are subject to tariffs that ...

School of Chemistry and Physics, Queensland University of Technology, Brisbane 4000, QLD, Australia Centre for Materials Science, Queensland University of Technology, Brisbane 4000, QLD, Australia ...

CVD Equipment has a 12-month low of $2.65 and a 12-month high of $6.13. The company has a current ratio of 2.99, a quick ratio of 2.60 and a debt-to-equity ratio of 0.01. The firm has a market cap ...